however the demise of the other chart was very much due to the lengthy legal battles which left a dark cloud hovering over that company for years, causing a number of other factors to slowly dilute the company down to the petty levels it now inhabits.
had the patent issue been handled differently, the chart would probably have looked more like that of ADO from jan10 onwards.
always good to remember that an oversimplified view like my thought bubble is just that, an appraisal of only one or two angles for novelty sake, not a philosophy on biosharetrading in general.
when you smile a little, it makes the wrinkles look like laughterlines...)
ANP Price at posting:
20.0¢ Sentiment: Buy Disclosure: Held
